home · filing · 0001437749-25-012697
8-K
filed April 22, 2025, 7:59 PM ET
ticker NRC
CIK 0000070487
leadership
confidence high
sentiment neutral
materiality 0.45
National Research designates CEO Hays as interim PFO, appoints Freeman as CAO
NRC HEALTH
CEO Michael D. Hays designated principal financial officer; will serve as PEO and PFO until Trent Green becomes CEO on June 1, 2025.
Jordan N. Freeman appointed Chief Accounting Officer and principal accounting officer, effective April 18, 2025.
No compensation changes were made in connection with either appointment.
Freeman previously served in accounting leadership roles at Nelnet and as a senior audit associate at Deloitte.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Jordan N. Freeman
Chief Accounting Officer
Effective 2025-04-18
Filed April 22, 2025, 7:59 PM ET
appointed Jordan N. Freeman as the Company’s Chief Accounting Officer.
Effective 2025-04-18
Filed April 22, 2025, 7:59 PM ET
designated Michael D. Hays, the Company’s Chief Executive Officer, to serve as the Company’s principal financial officer.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Jordan N. Freeman was appointed as Chief Accounting Officer at NRC HEALTH.
Action appointed
Role Chief Accounting Officer
Exact text from the filing
appointed Jordan N. Freeman as the Company’s Chief Accounting Officer.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 1.0
Michael D. Hays changed role as principal financial officer at NRC HEALTH.
Action designated
Role principal financial officer
Exact text from the filing
designated Michael D. Hays, the Company’s Chief Executive Officer, to serve as the Company’s principal financial officer.
View on SEC.gov
Source: SEC EDGAR
accession 0001437749-25-012697
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.